Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
IV hydrocortisone vs methylprednisolone vs dexamethasone for ARDS due to COVID-19
IRCT20120215009014N354Phase 2Completed
- Sponsor
- Hamadan University of Medical Sciences
- Start
- Jun 2020
- Modality
- Small Molecules, Orthosteric Ligands → Classical Binding Small Molecules → Small Molecules
- Countries
- 1
01
Overview
Phase 2 trial of hydrocortisone, methylprednisolone and dexamethasone in acute respiratory distress syndrome (ARDS) and coronavirus disease 2019 (COVID-19) (3 arms), sponsored by Hamadan University of Medical Sciences. Started Jun 2020; status: completed.
02
Drugs
hydrocortisonemethylprednisolonedexamethasone
03
Conditions
acute respiratory distress syndrome (ARDS)coronavirus disease 2019 (COVID-19)
Beyond the preview
Go deeper on IRCT20120215009014N354.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on IRCT20120215009014N354.